MMP9 and atrial fibrillation: Shensong Yangxin capsule was found to down-regulate MMP-9 and MMP inhibitor levels and improve left atrial conduction function by inhibiting left atrial fibrosis, which contributes to prevent the development of a myocardial infarction induced vulnerable substrate for AF (64).